skip to content
Pharmaceutical innovation, mortality reduction, and economic growth Preview this item
ClosePreview this item
Checking...

Pharmaceutical innovation, mortality reduction, and economic growth

Author: Frank R Lichtenberg; National Bureau of Economic Research.
Publisher: Cambridge, MA : National Bureau of Economic Research, ©1998.
Series: Working paper series (National Bureau of Economic Research), working paper no. 6569.
Edition/Format:   Print book : EnglishView all editions and formats
Summary:
Abstract: We perform an econometric investigation of the contribution of pharmaceutical innovation to mortality reduction and growth in lifetime per capita income. In both of the periods studied (1970-80 and 1980-91), there is a highly significant positive relationship across diseases between the increase in mean age at death (which is closely related to life expectancy) and rates of introduction of new, priority'  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Material Type: Internet resource
Document Type: Book, Internet Resource
All Authors / Contributors: Frank R Lichtenberg; National Bureau of Economic Research.
OCLC Number: 39511434
Notes: "May 1998."
Description: 28 pages : illustrations ; 22 cm.
Series Title: Working paper series (National Bureau of Economic Research), working paper no. 6569.
Responsibility: Frank R. Lichtenberg.

Abstract:

Abstract: We perform an econometric investigation of the contribution of pharmaceutical innovation to mortality reduction and growth in lifetime per capita income. In both of the periods studied (1970-80 and 1980-91), there is a highly significant positive relationship across diseases between the increase in mean age at death (which is closely related to life expectancy) and rates of introduction of new, priority' (as defined by the FDA) drugs. The estimates imply that in the absence of pharmaceutical innovation, there would have been no increase and perhaps even a small decrease in mean age at death, and that new drugs have increased life expectancy, and lifetime income, by about 0.75-1.0% per annum. The drug innovation measures are also strongly positively related to the reduction in life-years lost in both periods. Some of the more conservative estimates imply that a one-time R & D expenditure of about $15 billion subsequently saves 1.6 million life-years per year, whose annual value is about $27 billion. All age groups benefited from the arrival of new drugs in at least one of the two periods. Controlling for growth in inpatient and ambulatory care utilization either has no effect on the drug coefficient or significantly increases it.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/39511434> # Pharmaceutical innovation, mortality reduction, and economic growth
    a schema:Book, schema:CreativeWork ;
   library:oclcnum "39511434" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/mau> ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/41661648#Place/cambridge_ma> ; # Cambridge, MA
   schema:about <http://experiment.worldcat.org/entity/work/data/41661648#Topic/innovations_etats_unis> ; # Innovations--États-Unis
   schema:about <http://id.worldcat.org/fast/998272> ; # Life expectancy--Econometric models
   schema:about <http://id.worldcat.org/fast/1204155> ; # United States
   schema:about <http://experiment.worldcat.org/entity/work/data/41661648#Topic/drugs_effectiveness_united_states_econometric_models> ; # Drugs--Effectiveness--United States--Econometric models
   schema:about <http://experiment.worldcat.org/entity/work/data/41661648#Topic/industrie_pharmaceutique_etats_unis> ; # Industrie pharmaceutique--États-Unis
   schema:about <http://experiment.worldcat.org/entity/work/data/41661648#Topic/life_expectancy_united_states_econometric_models> ; # Life expectancy--United States--Econometric models
   schema:about <http://experiment.worldcat.org/entity/work/data/41661648#Topic/drugs_research_united_states_econometric_models> ; # Drugs--Research--United States--Econometric models
   schema:about <http://experiment.worldcat.org/entity/work/data/41661648#Topic/pharmaceutical_industry_technological_innovations_united_states_econometric_models> ; # Pharmaceutical industry--Technological innovations--United States--Econometric models
   schema:about <http://experiment.worldcat.org/entity/work/data/41661648#Topic/esperance_de_vie_etats_unis> ; # Espérance de vie--États-Unis
   schema:about <http://dewey.info/class/330/> ;
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <http://viaf.org/viaf/135446122> ; # National Bureau of Economic Research.
   schema:copyrightYear "1998" ;
   schema:creator <http://experiment.worldcat.org/entity/work/data/41661648#Person/lichtenberg_frank_r> ; # Frank R. Lichtenberg
   schema:datePublished "1998" ;
   schema:description "Abstract: We perform an econometric investigation of the contribution of pharmaceutical innovation to mortality reduction and growth in lifetime per capita income. In both of the periods studied (1970-80 and 1980-91), there is a highly significant positive relationship across diseases between the increase in mean age at death (which is closely related to life expectancy) and rates of introduction of new, priority' (as defined by the FDA) drugs. The estimates imply that in the absence of pharmaceutical innovation, there would have been no increase and perhaps even a small decrease in mean age at death, and that new drugs have increased life expectancy, and lifetime income, by about 0.75-1.0% per annum. The drug innovation measures are also strongly positively related to the reduction in life-years lost in both periods. Some of the more conservative estimates imply that a one-time R & D expenditure of about $15 billion subsequently saves 1.6 million life-years per year, whose annual value is about $27 billion. All age groups benefited from the arrival of new drugs in at least one of the two periods. Controlling for growth in inpatient and ambulatory care utilization either has no effect on the drug coefficient or significantly increases it."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/41661648> ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/41661648#Series/nber_working_paper_series> ; # NBER working paper series ;
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/41661648#Series/working_paper_series_national_bureau_of_economic_research> ; # Working paper series (National Bureau of Economic Research) ;
   schema:name "Pharmaceutical innovation, mortality reduction, and economic growth"@en ;
   schema:productID "39511434" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/39511434#PublicationEvent/cambridge_ma_national_bureau_of_economic_research_1998> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/41661648#Agent/national_bureau_of_economic_research> ; # National Bureau of Economic Research
   schema:url <http://papers.nber.org/papers/w6569> ;
   schema:url <http://dx.doi.org/10.3386/w6569> ;
   schema:url <http://www.nber.org/papers/w6569> ;
   schema:url <http://ezproxy.eui.eu/login?url=http://papers.nber.org/papers/> ;
   umbel:isLike <http://bnb.data.bl.uk/id/resource/GB9854193> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/39511434> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/41661648#Agent/national_bureau_of_economic_research> # National Bureau of Economic Research
    a bgn:Agent ;
   schema:name "National Bureau of Economic Research" ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Person/lichtenberg_frank_r> # Frank R. Lichtenberg
    a schema:Person ;
   schema:familyName "Lichtenberg" ;
   schema:givenName "Frank R." ;
   schema:name "Frank R. Lichtenberg" ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Series/nber_working_paper_series> # NBER working paper series ;
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/39511434> ; # Pharmaceutical innovation, mortality reduction, and economic growth
   schema:name "NBER working paper series ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Series/working_paper_series_national_bureau_of_economic_research> # Working paper series (National Bureau of Economic Research) ;
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/39511434> ; # Pharmaceutical innovation, mortality reduction, and economic growth
   schema:name "Working paper series (National Bureau of Economic Research) ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Topic/drugs_effectiveness_united_states_econometric_models> # Drugs--Effectiveness--United States--Econometric models
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85039729> ;
   schema:name "Drugs--Effectiveness--United States--Econometric models"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Topic/drugs_research_united_states_econometric_models> # Drugs--Research--United States--Econometric models
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh2009123934> ;
   schema:name "Drugs--Research--United States--Econometric models"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Topic/esperance_de_vie_etats_unis> # Espérance de vie--États-Unis
    a schema:Intangible ;
   schema:name "Espérance de vie--États-Unis"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Topic/industrie_pharmaceutique_etats_unis> # Industrie pharmaceutique--États-Unis
    a schema:Intangible ;
   schema:name "Industrie pharmaceutique--États-Unis"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Topic/innovations_etats_unis> # Innovations--États-Unis
    a schema:Intangible ;
   schema:name "Innovations--États-Unis"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Topic/life_expectancy_united_states_econometric_models> # Life expectancy--United States--Econometric models
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85076821> ;
   schema:name "Life expectancy--United States--Econometric models"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/41661648#Topic/pharmaceutical_industry_technological_innovations_united_states_econometric_models> # Pharmaceutical industry--Technological innovations--United States--Econometric models
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85039715> ;
   schema:name "Pharmaceutical industry--Technological innovations--United States--Econometric models"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States
    a schema:Place ;
   schema:name "United States" ;
    .

<http://id.worldcat.org/fast/998272> # Life expectancy--Econometric models
    a schema:Intangible ;
   schema:name "Life expectancy--Econometric models"@en ;
    .

<http://viaf.org/viaf/135446122> # National Bureau of Economic Research.
    a schema:Organization ;
   schema:name "National Bureau of Economic Research." ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.